CN103784814A - Medicinal composition for preventing and treating dust phthisis - Google Patents
Medicinal composition for preventing and treating dust phthisis Download PDFInfo
- Publication number
- CN103784814A CN103784814A CN201410054980.3A CN201410054980A CN103784814A CN 103784814 A CN103784814 A CN 103784814A CN 201410054980 A CN201410054980 A CN 201410054980A CN 103784814 A CN103784814 A CN 103784814A
- Authority
- CN
- China
- Prior art keywords
- parts
- pneumoconiosis
- prevention
- pharmaceutical composition
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The invention relates to a medicinal composition for preventing and treating dust phthisis. The medicinal composition for preventing and treating dust phthisis is prepared from the following components in parts by weight: 27-33 parts of acanthopanax root, 13-18 parts of mulberry leaf, 5-10 parts of ginkgo, 7-14 parts of corsvenor momordica fruit, 10-15 parts of pearl barley, 18-23 parts of dandelion, 13-17 parts of bitter bamboo leaf, 3-8 parts of heartleaf houttuynia herb, 16-20 parts of common anemarrhena, 11-15 parts of common bletilla tuber, 15-18 parts of barbary wolfberry fruit and 10-15 parts of gecko. The medicinal composition for preventing and treating dust phthisis is low in price and definite in curative effect. By reasonably combining effective components and adjuvant components, supplementary and coordinative effects are achieved. The medicinal composition has the advantages of short treatment course, quick response and good curative effect. By combining pure natural raw medicaments, side effects, dependency and drug resistance are eliminated. The medicinal composition is widely suitable for the prevention, control and treatment of dust phthisis.
Description
Technical field
The present invention relates to the pharmaceutical composition of a kind of prevention and treatment pneumoconiosis.
Background technology
Pneumoconiosis is to suck industrial dust due to long-term in vocational activity, and in lung retention and cause take lung tissue diffuse fibrosis as main systemic disease.Pneumoconiosis is mainly to suck due to inorganic dust, and the difference such as kind and work post that sucks dust by it, can be divided into 13 kinds of pneumoconiosis.The legal 13 kinds of pneumoconiosis of China have: pneumosilicosis, coal-worker's pnuemoconiosis, graphite pneumoconiosis, carbon ink pneumoconiosis, talc pneumoconiosis, cement pneumoconiosis, mica pneumoconiosis, kaolin pneumoconiosis, aluminosis, electric welder pneumoconiosis, foundry worker pneumoconiosis, asbestosis and other pneumoconiosis.The demonstration of Ministry of Public Health data, by the end of the year 2009, whole nation accumulative total reports occupation disease 722,730 examples, wherein pneumoconiosis 65.3 ten thousand examples.Pneumoconiosis number of cases accounts for occupation disease sum more than 90%.Pneumoconiosis is the most serious occupation disease of harm China workers ' health, is a disabling condition that there is no medical treatment termination.Domestic pneumoconiosis cumulative cases and suspicious pneumoconiosis (0+) case nearly 1,000,000 are reported by authoritative institution at present, especially attach most importance to coal system, the direct economic loss that annual pneumoconiosis causes to country reaches 8,000,000,000 yuan, also causes bad political fallout simultaneously at home and abroad.In the face of numerous existing patients, enterprise is the heavier coal industry of historical burden particularly, face put an enterprise under a lower administrative level, in the difficult situation of structural adjustment, be difficult to a large amount of patients to treat timely and effectively, and in society, be studded with especially many with employing unit depart from Pneumoconiosis Patients, become the disadvantaged group of being badly in need of relief, these have all developed into more and more serious social problem.The treatment of pneumoconiosis is without specific treatment method, effectively treatment is lung lavage treatment at present, also be the new technique growing up over nearly 20 years, because it can remove dust in part lung, improve symptom and pulmonary function, improve patients ' life quality, enjoy the welcome of extensive patients, but the expenditure of each units up to ten thousand becomes again patient's burden.Therefore, exploitation has the Traditional chinese medicine medicament that feature, determined curative effect, taking convenience, patient can life-time service, and the compound Chinese medicinal preparation that forms bright characteristic has important society and economic implications.
Summary of the invention
The technical problem to be solved in the present invention is the above-mentioned defect that how to overcome prior art, and the pharmaceutical composition of a kind of prevention and treatment pneumoconiosis is provided.
For solving the problems of the technologies described above, this prevention and treatment pneumoconiosis pharmaceutical composition by following component according to shown in weight ratio scope formulated, 27～33 parts of Radix Et Caulis Acanthopanacis Senticosis, 13～18 parts of Folium Mori, 5～10 parts of Semen Ginkgoes, 7～14 parts of Fructus Momordicaes, 10～15 parts of Semen Coiciss, 18～23 parts of Herba Taraxacis, 13～17 parts of Folium Pleioblastis, 3～8 parts of Herba Houttuyniae, 16～20 parts of the Rhizoma Anemarrhenaes, 11～15 parts of the Pseudobulbus Bletillae (Rhizoma Bletillae)s, 15～18 parts of Fructus Lyciis, 10～15 parts of Geckos.
As optimum ratio, described pharmaceutical composition by following component according to shown in weight ratio scope formulated, 29～31 parts of Radix Et Caulis Acanthopanacis Senticosis, 15～17 parts of Folium Mori, 7～9 parts of Semen Ginkgoes, 9～11 parts of Folium Momordicaes, 11～13 parts of Semen Coiciss, 15～17 parts of Herba Taraxacis, 12～14 parts of Folium Pleioblastis, 5～7 parts of Herba Houttuyniae, 17～19 parts of the Rhizoma Anemarrhenaes, 13～15 parts of the Pseudobulbus Bletillae (Rhizoma Bletillae)s, 16～18 parts of Fructus Lyciis, 11～13 parts of Geckos.
As best proportioning, described pharmaceutical composition by following component according to shown in weight ratio formulated, 30 parts of Radix Et Caulis Acanthopanacis Senticosis, 16 parts of Folium Mori, 8 parts of Semen Ginkgoes, 10 parts of Folium Momordicaes, 12 parts of Semen Coiciss, 16 parts of Herba Taraxacis, 13 parts of Folium Pleioblastis, 6 parts of Herba Houttuyniae, 18 parts of the Rhizoma Anemarrhenaes, 14 parts of the Pseudobulbus Bletillae (Rhizoma Bletillae)s, 17 parts of Fructus Lyciis, 12 parts of Geckos.
As optimization, the medicine composition dosage form of this prevention and treatment pneumoconiosis is tablet, capsule, injectable powder or granule.
The preparation method of the medicinal composition tablets of this prevention and treatment pneumoconiosis is, take each component by above-mentioned weight portion proportioning, add 35%～50% filler, binding agent, disintegrating agent, lubricant, correctives etc., fully be uniformly mixed granulation, by the wet granular of making 60～70 ℃ of dry 2～4h compactings in flakes, obtain the medicinal composition tablets of this prevention and treatment pneumoconiosis.
The preparation method of the medicament composition capsule agent of this prevention and treatment pneumoconiosis is, take each component by above-mentioned weight portion proportioning, add 35%～50% filler, binding agent, disintegrating agent, lubricant, correctives etc., fully be uniformly mixed granulation, the wet granular of making is dried to 2～4h at 60～70 ℃, then be filled in hungry area shell, obtain the medicament composition capsule agent of this prevention and treatment pneumoconiosis.
The preparation method of the medicinal composition freezing-dried powder injection of this prevention and treatment pneumoconiosis is, take each component by above-mentioned weight portion proportioning, add 60%～80% solvent, antiseptic, fully mix, add activated carbon decolorizing, filter, with being less than the micro-air filter membrane filtration of 0.45 μ m, embedding after ultrafiltration, 100 ℃ of sterilizing 30～60h, make every mL containing compositions 500mg; Or by gained filtrate by after standard subpackage, lyophilization under vacuum condition, obtains the medicinal composition freezing-dried powder injection of this prevention and treatment pneumoconiosis.
The preparation method of the medicament composition granule agent of this prevention and treatment pneumoconiosis is, take each component by above-mentioned weight portion proportioning, add 45%～75% filler, disintegrating agent, correctives etc., fully be uniformly mixed with 12～14 mesh sieve granulations, at 60-70 ℃ of dry 2～4h, make every gram of granule containing each components composition 800mg, obtain the medicament composition granule agent of this prevention and treatment pneumoconiosis.
Pharmacology analysis:
Radix Et Caulis Acanthopanacis Senticosi: acrid in the mouth, hardship, micro-sweet, temperature; Return liver, kidney channel; Rheumatism, invigorating the liver and kidney, bone and muscle strengthening, the arteries and veins of invigorating blood circulation, is applicable to anemofrigid-damp arthralgia; Lumbocrural pain; Muscles and bones flaccidity is soft; Be slow in action; A little less than body weakness with emaciation; Traumatic injury; Fracture; Edema; Foot gas; Uncontrolled urination is itched.
Folium Mori: sweet in the mouth, cool in nature; Brill muscle is deep, applies carbuncle, pulls out furuncle, draws all loose poison counteracting toxic substances.
Semen Ginkgo: mildly bitter flavor, property is flat; GUIXIN, lung meridian; Astringe the lung, relieving asthma, blood circulation promoting and blood stasis dispelling, pain relieving, for cough and asthma due to lung deficiency; Coronary heart disease, angina pectoris, hyperlipidemia, anticoagulant is solid.
Fructus Momordicae: sweet in the mouth, cool in nature; Return lung, large intestine channel; Clearing heat and moistening lung, cough-relieving, sore-throat relieving, laxation relieving constipation, for lung-fire cough caused by dryness, pharyngalgia aphonia, dryness of the intestine constipation.
Semen Coicis: slightly sweet flavor, be slightly cold, nontoxic; Enter spleen, stomach, lung, large intestine; Clearing away heat-damp and promoting diuresis, except rheumatism, diuresis, lung benefiting evacuation of pus, strengthening the spleen and stomach, bone and muscle strengthening, wet general pain, hygropyretic beriberi, damp and hot muscular contracture contracture, arthralgia chiefly caused by damp pathogen, edema, the lung lung abscess of withering, coughs vomiting bloody pus, sore throat carbuncle, acute appendicitis pyretic stranguria.
Herba Taraxaci: sweet in the mouth, micro-hardship, cold in nature; Enter spleen, stomach, kidney three warps; Heat-clearing and toxic substances removing, eliminating carbuncle eliminating stagnation.
Folium Pleioblasti: bitter in the mouth, property is cold, nontoxic; Clearing heat and relieving fidgetness, quenches one's thirst, diuresis; Thirsty for fever and irritability, aphtha of the mouth and tongue, oliguria yellow skin.
Herba Houttuyniae: acrid in the mouth, slightly warm in nature, slightly poisonous; Enter liver, lung two warps; Heat-clearing and toxic substances removing, inducing diuresis to remove edema, controls pneumonia, lung abscess, hematodiarrhoea, malaria, edema, gonorrhea, leucorrhea, carbuncle, hemorrhoid, proctoptosis, eczema, tinea alba, scabies.
The Rhizoma Anemarrhenae: bitter in the mouth, sweet, cold in nature; Return lung, stomach, kidney channel; Clearing away heat-fire, promotes the production of body fluid and moisturizes.Clearing away heat-fire, promotes the production of body fluid and moisturizes.For fever caused by exogenous pathogenic factors, high hot excessive thirst, lung-heat type cough, osteopyrexia and fever, interior-heat is quenched one's thirst, dryness of the intestine constipation.
The Pseudobulbus Bletillae (Rhizoma Bletillae): acrid in the mouth, bitter, sweet, puckery, be slightly cold; Return lung, liver, stomach warp; Control consumptive disease impairing the lung gas, tonifying the lung void, cough-relieving is coughed, the pulmonary tuberculosis that disappears hemoptysis, convergence lung qi.
Fructus Lycii: sweet in the mouth, property is flat; Return Liver Channel; Kidney channel; Lung meridian; Nourishing the liver, nourishing kidney, lung moistening, control caused by liver and kidney deficiency, has a dizzy spell, visual unclear, soreness of the waist and knees, impotence and seminal emission, cough due to consumptive disease, the taking fluids profusely of quenching one's thirst.
Gecko: salty in the mouth is flat, slightly poisonous; Enter lung, kidney channel; Tonifying the lung gas, benefiting essence-blood, Dingchuan antitussive, treats lung abscess and quenches one's thirst, supporing yang road, main lung impairment and cough of a specified duration, pouring drop person, all lung kidney is disease, the labor utmost point lung is suffered from a deficiency of the kidney and heat-dissipating, therefore exopathogen is easily invaded, internal evidence is held concurrently and sent out also, it is cloudy that clam Eriocheir sinensis belongs to, can moisturizing on source, lung kidney all support, and consumptive fever cough removes certainly, the convergence of vessels in the lung, regulating fluid apssage, lower defeated bladder, normal lung-QI, therefore drench dewatering road from leading to also.
The pharmaceutical composition of a kind of prevention of the present invention and treatment pneumoconiosis is cheap, determined curative effect, mutually supplement and coordinate by active ingredient and reasonable compatibility, effect of each component of assisting a ruler in governing a country composition, there is short treating period, instant effect, the advantages such as good effect, and be pure natural crude drug compatibility, can not have side effects, dependency and Drug resistance, be widely used in prevention, control and the treatment of pneumoconiosis.
The specific embodiment
Embodiment 1: take each component by the weight portion proportioning of 30 parts of Radix Et Caulis Acanthopanacis Senticosis, 16 parts of Folium Mori, 8 parts of Semen Ginkgoes, 10 parts of Folium Momordicaes, 12 parts of Semen Coiciss, 16 parts of Herba Taraxacis, 13 parts of Folium Pleioblastis, 6 parts of Herba Houttuyniae, 18 parts of the Rhizoma Anemarrhenaes, 14 parts of the Pseudobulbus Bletillae (Rhizoma Bletillae)s, 17 parts of Fructus Lyciis, 12 parts of Geckos, add 35%～50% lactose, gelatin, microcrystalline Cellulose, lubricant, magnesium stearate, fully be uniformly mixed granulation, by the wet granular of making 60～70 ℃ of dry 2～4h compactings in flakes, obtain the medicinal composition tablets of this prevention and treatment pneumoconiosis.
Embodiment 2: press 31 parts of Radix Et Caulis Acanthopanacis Senticosis, 15 parts of Folium Mori, 9 parts of Semen Ginkgoes, 9 parts of Folium Momordicaes, 13 parts of Semen Coiciss, 15 parts of Herba Taraxacis, 14 parts of Folium Pleioblastis, 5 parts of Herba Houttuyniae, 19 parts of the Rhizoma Anemarrhenaes, 13 parts of the Pseudobulbus Bletillae (Rhizoma Bletillae)s, 18 parts of Fructus Lyciis, the weight portion proportioning that Gecko is 11 parts takes each component, add 35%～50% starch, hydroxypropyl emthylcellulose, carboxymethyl starch sodium, propyl methocel, fully be uniformly mixed granulation, the wet granular of making is dried to 2～4h at 60～70 ℃, then be filled in hungry area shell, obtain the medicament composition capsule agent of this prevention and treatment pneumoconiosis.
Embodiment 3: take each component by the weight portion proportioning of 27 parts of Radix Et Caulis Acanthopanacis Senticosis, 18 parts of Folium Mori, 5 parts of Semen Ginkgoes, 14 parts of Fructus Momordicaes, 10 parts of Semen Coiciss, 23 parts of Herba Taraxacis, 13 parts of Folium Pleioblastis, 8 parts of Herba Houttuyniae, 16 parts of the Rhizoma Anemarrhenaes, 15 parts of the Pseudobulbus Bletillae (Rhizoma Bletillae)s, 15 parts of Fructus Lyciis, 15 parts of Geckos, add 60%～80% water-ethanol mixed solvent, sorbitol, fully mix, add activated carbon decolorizing, filter, with being less than the micro-air filter membrane filtration of 0.45 μ m, embedding after ultrafiltration, 100 ℃ of sterilizing 30～60h, make every mL containing compositions 500mg; Or by gained filtrate by after standard subpackage, lyophilization under vacuum condition, obtains the medicinal composition freezing-dried powder injection of this prevention and treatment pneumoconiosis.
Embodiment 4: take each component by the weight portion proportioning of 33 parts of Radix Et Caulis Acanthopanacis Senticosis, 13 parts of Folium Mori, 10 parts of Semen Ginkgoes, 7 parts of Fructus Momordicaes, 15 parts of Semen Coiciss, 18 parts of Herba Taraxacis, 17 parts of Folium Pleioblastis, 3 parts of Herba Houttuyniae, 20 parts of the Rhizoma Anemarrhenaes, 11 parts of the Pseudobulbus Bletillae (Rhizoma Bletillae)s, 18 parts of Fructus Lyciis, 10 parts of Geckos, add 45%～75% microcrystalline Cellulose, dextrin, polyvinylpyrrolidone, fully be uniformly mixed with 12～14 mesh sieve granulations, at 60-70 ℃ of dry 2～4h, make every gram of granule containing each components composition 800mg, obtain the medicament composition granule agent of this prevention and treatment pneumoconiosis.
Clinical case: (medicinal composition tablets of this prevention and treatment pneumoconiosis)
Medicinal composition tablets through oral prevention of clinical 157 routine patient and treatment pneumoconiosis is treated 12 months altogether; Matched group patient 88 examples, take placebo (not containing the alike starch sheet of any pharmaceutical component, profile and medicine provided by the present invention).Result shows, treatment group patient's cough, cough up phlegm, the symptom such as chest pain and dyspnea obviously improves, effective percentage is respectively 62.0%～73.0%; Patient's flu and Bronchopulmonary infection obviously reduce; X-ray rabat pathological changes is in improvement or steady statue, difference significance compared with matched group (P < 0.05); Pulmonary ventilation function (FVC and FEV1) after treatment is significantly increased (P < 0.01) before treating.The above results shows that the medicinal composition tablets of this prevention and treatment pneumoconiosis has significant curative effect.Be down some cases:
Case 1: beam, man, 68 years old, III phase pneumoconiosis, pulmonary function second phase, three courses for the treatment of of medicinal composition tablets of taking this prevention and treatment pneumoconiosis.Patient reacts well, has no side effect, and symptom is significantly alleviated.
Case 2: Feng, man, 71 years old, II phase pneumoconiosis, pulmonary function second phase, continuous two courses for the treatment of of medicinal composition tablets of taking this prevention and treatment pneumoconiosis.Patient's symptom alleviates, and has no side effect.
Case 3: Zhao, man, 59 years old, I phase pneumoconiosis, the pulmonary function second phase, provide through inventor, take continuous three courses for the treatment of of medicinal composition tablets of this prevention and treatment pneumoconiosis.Patient's transference cure, has no side effect.
Above-mentioned embodiment is intended to illustrate the present invention and can be professional and technical personnel in the field's realization or use; it will be apparent for those skilled in the art that above-mentioned embodiment is modified; therefore the present invention includes but be not limited to above-mentioned embodiment; any these claims or description of meeting described; meet and principle disclosed herein and novelty, the method for inventive features, technique, product, within all falling into protection scope of the present invention.
Claims (8)
1. a pharmaceutical composition that prevents and treat pneumoconiosis, it is characterized in that: by following component according to shown in weight ratio scope formulated, 27～33 parts of Radix Et Caulis Acanthopanacis Senticosis, 13～18 parts of Folium Mori, 5～10 parts of Semen Ginkgoes, 7～14 parts of Fructus Momordicaes, 10～15 parts of Semen Coiciss, 18～23 parts of Herba Taraxacis, 13～17 parts of Folium Pleioblastis, 3～8 parts of Herba Houttuyniae, 16～20 parts of the Rhizoma Anemarrhenaes, 11～15 parts of the Pseudobulbus Bletillae (Rhizoma Bletillae)s, 15～18 parts of Fructus Lyciis, 10～15 parts of Geckos.
2. the pharmaceutical composition of prevention according to claim 1 and treatment pneumoconiosis, it is characterized in that: described pharmaceutical composition by following component according to shown in weight ratio scope formulated, 29～31 parts of Radix Et Caulis Acanthopanacis Senticosis, 15～17 parts of Folium Mori, 7～9 parts of Semen Ginkgoes, 9～11 parts of Folium Momordicaes, 11～13 parts of Semen Coiciss, 15～17 parts of Herba Taraxacis, 12～14 parts of Folium Pleioblastis, 5～7 parts of Herba Houttuyniae, 17～19 parts of the Rhizoma Anemarrhenaes, 13～15 parts of the Pseudobulbus Bletillae (Rhizoma Bletillae)s, 16～18 parts of Fructus Lyciis, 11～13 parts of Geckos.
3. the pharmaceutical composition of prevention according to claim 2 and treatment pneumoconiosis, it is characterized in that: described pharmaceutical composition by following component according to shown in weight ratio formulated, 30 parts of Radix Et Caulis Acanthopanacis Senticosis, 16 parts of Folium Mori, 8 parts of Semen Ginkgoes, 10 parts of Folium Momordicaes, 12 parts of Semen Coiciss, 16 parts of Herba Taraxacis, 13 parts of Folium Pleioblastis, 6 parts of Herba Houttuyniae, 18 parts of the Rhizoma Anemarrhenaes, 14 parts of the Pseudobulbus Bletillae (Rhizoma Bletillae)s, 17 parts of Fructus Lyciis, 12 parts of Geckos.
4. according to the pharmaceutical composition of the arbitrary described prevention of claims 1 to 3 and treatment pneumoconiosis, it is characterized in that: this medicine composition dosage form is tablet, capsule, injectable powder or granule.
5. the pharmaceutical composition of prevention according to claim 4 and treatment pneumoconiosis, is characterized in that: this medicine composition dosage form is tablet; Its preparation method is, take each component by the weight portion proportioning as described in as arbitrary in claims 1 to 3, add 35%～50% filler, binding agent, disintegrating agent, lubricant, correctives etc., fully be uniformly mixed granulation, by the wet granular of making 60～70 ℃ of dry 2～4h compactings in flakes, obtain the medicinal composition tablets of this prevention and treatment pneumoconiosis.
6. the pharmaceutical composition of prevention according to claim 4 and treatment pneumoconiosis, is characterized in that: this medicine composition dosage form is capsule; Its preparation method is, take each component by the weight portion proportioning as described in as arbitrary in claims 1 to 3, add 35%～50% filler, binding agent, disintegrating agent, lubricant, correctives etc., fully be uniformly mixed granulation, the wet granular of making is dried to 2～4h at 60～70 ℃, then be filled in hungry area shell, obtain the medicament composition capsule agent of this prevention and treatment pneumoconiosis.
7. the pharmaceutical composition of prevention according to claim 4 and treatment pneumoconiosis, is characterized in that: this medicine composition dosage form is lyophilized injectable powder; Its preparation method is, take each component by the weight portion proportioning as described in as arbitrary in claims 1 to 3, add 60%～80% solvent, antiseptic, fully mix, add activated carbon decolorizing, filter, with being less than the micro-air filter membrane filtration of 0.45 μ m, embedding after ultrafiltration, 100 ℃ of sterilizing 30～60h, make every mL containing compositions 500mg; Or by gained filtrate by after standard subpackage, lyophilization under vacuum condition, obtains the medicinal composition freezing-dried powder injection of this prevention and treatment pneumoconiosis.
8. the pharmaceutical composition of prevention according to claim 4 and treatment pneumoconiosis, is characterized in that: this medicine composition dosage form is granule; Its preparation method is, take each component by the weight portion proportioning as described in as arbitrary in claims 1 to 3, add 45%～75% filler, disintegrating agent, correctives etc., fully be uniformly mixed with 12～14 mesh sieve granulations, at 60-70 ℃ of dry 2～4h, make every gram of granule containing each components composition 800mg, obtain the medicament composition granule agent of this prevention and treatment pneumoconiosis.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410054980.3A CN103784814A (en) | 2014-02-18 | 2014-02-18 | Medicinal composition for preventing and treating dust phthisis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410054980.3A CN103784814A (en) | 2014-02-18 | 2014-02-18 | Medicinal composition for preventing and treating dust phthisis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103784814A true CN103784814A (en) | 2014-05-14 |
Family
ID=50661151
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410054980.3A Pending CN103784814A (en) | 2014-02-18 | 2014-02-18 | Medicinal composition for preventing and treating dust phthisis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103784814A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105079479A (en) * | 2015-09-01 | 2015-11-25 | 高丙军 | Method for preventing silicosis |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1059848A (en) * | 1990-09-19 | 1992-04-01 | 赵会廷 | A kind of treatment pneumoconiosis process for preparing medicine |
| CN1328847A (en) * | 2001-07-05 | 2002-01-02 | 高树良 | Chinese medicine preparation for curing pneumoconiosis |
-
2014
- 2014-02-18 CN CN201410054980.3A patent/CN103784814A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1059848A (en) * | 1990-09-19 | 1992-04-01 | 赵会廷 | A kind of treatment pneumoconiosis process for preparing medicine |
| CN1328847A (en) * | 2001-07-05 | 2002-01-02 | 高树良 | Chinese medicine preparation for curing pneumoconiosis |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105079479A (en) * | 2015-09-01 | 2015-11-25 | 高丙军 | Method for preventing silicosis |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104547496B (en) | A kind of Chinese medicine composition to moisten the lung and relieve the cough and preparation method thereof | |
| CN103055260A (en) | Traditional Chinese medicine composition for treating ulcerative colitis and preparation method thereof | |
| CN104784548A (en) | Traditional Chinese medicine composition for treating cough and application thereof | |
| CN104800549A (en) | Traditional Chinese medicine composition for treating chronic bronchitis | |
| CN111588828A (en) | Chinese medicinal preparation for treating new coronavirus and viral diseases, and its preparation method | |
| CN105535389A (en) | Traditional Chinese medicinal composition for treating lumbar and cervical bone hyperplasia and preparation method thereof | |
| CN102416144A (en) | Chinese medicine for treating infantile convulsions | |
| CN104689247A (en) | Traditional Chinese preparation for treating pneumoconiosis and preparation method thereof | |
| CN106334171B (en) | A kind of Chinese medicine preparation and preparation method for being used to repair hepatic injury | |
| CN104645078A (en) | Traditional Chinese medicine composition for treating migraine | |
| CN114767824A (en) | Preparation for treating laryngeal cough and preparation method thereof | |
| CN103784814A (en) | Medicinal composition for preventing and treating dust phthisis | |
| CN105327285A (en) | Medicine used for treating antral gastritis | |
| CN105311460A (en) | Traditional Chinese medicine for treating vascular neuralgia headache | |
| CN104225558A (en) | Quick-acting external use patch for pneumonia and preparation method thereof | |
| CN104274682A (en) | Traditional Chinese medicine composition for treating coal workers' pneumoconiosis and preparation method of traditional Chinese medicine composition | |
| CN1162163C (en) | Chinese herbal medicinal liquor for curing rheumatic arthritis | |
| CN101129651A (en) | Traditional Chinese medicine formulated product for treating cervical vertebra disease | |
| CN105663850A (en) | Traditional Chinese medicine composition for treating oral ulcer | |
| CN105641228A (en) | Traditional Chinese medicine decoction capable of effectively treating anemopyretic cold and preparation method | |
| CN104547512A (en) | Pharmaceutical composition for treating pharyngeal diseases, as well as preparation method thereof | |
| CN105560753A (en) | Medicine for curing scapulohumeral periarthritis and preparing method | |
| CN105878664A (en) | Chinese and western medicine combined prescription for treating dental ulcer | |
| CN105288174A (en) | Traditional Chinese medicine for treating ulcerative colitis | |
| CN1294963C (en) | Oral liquid for curing burn and process for preparing the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20140514 |
|
| RJ01 | Rejection of invention patent application after publication |